Cargando…
Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood–Brain Barrier Adherence, Uptake, and Permeation
Novel stroke therapies are needed. Inhibition of the interaction between the postsynaptic density-95 (PSD-95)/disc large/ZO-1 (PDZ) domains of PSD-95 and the N-methyl-D-aspartate (NMDA) receptor has been suggested as a strategy for relieving neuronal damage. The peptides NR2B9c and N-dimer have been...
Autores principales: | Kristensen, Mie, Kucharz, Krzysztof, Felipe Alves Fernandes, Eduardo, Strømgaard, Kristian, Schallburg Nielsen, Morten, Cederberg Helms, Hans Christian, Bach, Anders, Ulrikkaholm Tofte-Hansen, Malte, Irene Aldana Garcia, Blanca, Lauritzen, Martin, Brodin, Birger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408072/ https://www.ncbi.nlm.nih.gov/pubmed/32674358 http://dx.doi.org/10.3390/pharmaceutics12070661 |
Ejemplares similares
-
Chemical shift assignments of the N-terminal domain of PSD95 (PSD95-NT)
por: Zhang, Yonghong, et al.
Publicado: (2021) -
Site-specific phosphorylation of PSD-95 dynamically regulates the postsynaptic density as observed by phase separation
por: Vistrup-Parry, Maria, et al.
Publicado: (2021) -
Multiple axons and actions with PSD-95
por: Williams, Ruth
Publicado: (2008) -
Durable fear memories require PSD-95
por: Fitzgerald, Paul J., et al.
Publicado: (2014) -
FMRP: a triple threat to PSD-95
por: Westmark, Cara J.
Publicado: (2013)